MedTrace Logo

Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

NCT06111183 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-02-12

No results posted yet for this study

Summary

This is a phase 2 study performed in diabetic foot ulcer (DFU) patients with chronic non-healing, neuro-ischemic wounds to investigate the safety, tolerability and efficacy of AUP1602-C.

Conditions

  • Diabetic Foot Ulcer

Interventions

OTHER

Placebo

Placebo is topically applied on chronic wounds and covered by wound dressing.

BIOLOGICAL

AUP1602-C

AUP1602-C is topically applied on chronic wounds and covered by wound dressing.

Sponsors & Collaborators

  • Aurealis Oy

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-21
Primary Completion
2025-11-28
Completion
2025-11-28

Countries

  • Germany
  • Italy
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06111183 on ClinicalTrials.gov